PTX-COVID19-B
From EverybodyWiki Bios & Wiki
| Vaccine description | |
|---|---|
| Target disease | COVID-19 |
| Type | mRNA |
| Clinical data | |
| Routes of administration | Intramuscular |
| Identifiers | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}} |
| Part of a series on the |
| COVID-19 pandemic |
|---|
|
|
|
International response |
|
Medical response |
|
PTX-COVID19-B is a messenger RNA (mRNA)-based COVID-19 vaccine, a vaccine for the prevention of the COVID-19 disease caused by an infection of the SARS-CoV-2 coronavirus, created by Providence Therapeutics, a Canadian drug company.[1]
References
- ↑ "Made-in-Canada coronavirus vaccine starts human clinical trials". Canadian Broadcasting Corporation. 26 January 2021.
External links
| This article about the COVID-19 pandemic is a stub. You can help EverybodyWiki by expanding it. |
| This pharmacology-related article is a stub. You can help EverybodyWiki by expanding it. |
| This Canada-related article is a stub. You can help EverybodyWiki by expanding it. |
This article "PTX-COVID19-B" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:PTX-COVID19-B. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
| This page exists already on Wikipedia. |

